Nuvaira was founded by Martin Mayse, Steve Dimmer in 2008.

Who are Nuvaira's investors?

Nuvaira's investors include Windham Capital Partners, Lightstone Ventures, Qiming Venture Partners.

How much funding has Nuvaira raised?

Nuvaira has disclosed $154.3M raised across 8 rounds.

Where is Nuvaira headquartered?

Nuvaira is headquartered in Minneapolis, US.

Nuvaira

Minneapolis, US · Founded 2008 · Delaware corporation · 19 employees on LinkedIn · 3 known investors

Find your way into Nuvaira

290 people in our graph share verified history with the Nuvaira team — schools, employers, funds. One of them is your warm intro.

Scott Williamsonunlockedknows Lisa Flaherty · together at University of California, Berkeley, Haas School of Business (overlapped)

×2knows the team · via University of California, Berkeley, Haas School of Business

knows the team · via Augsburg University

×5knows the team · via Yale School of Medicine

knows the team · via Université de Montpellier Paul-Valéry

knows the team · via University of California, San Francisco - School of Medicine

Nuvaira develops the dNerva Lung Denervation System, a catheter-based device used in a one-time, outpatient bronchoscopic procedure that disrupts pulmonary nerve input to treat chronic obstructive pulmonary disease (COPD). The treatment targets COPD patients with lung hyperinflation and low emphysema, aiming to preserve lung function, reduce breathlessness, and lower exacerbations.

Hardware Healthtech Medical Devices

Founders & leadership

Nuvaira was founded in 2008 by Martin Mayse and Steve Dimmer.

Martin Mayse inFounderMartin Mayse is a co-founder of Nuvaira and a board-certified physician in internal medicine and pulmonary medicine with fellowship training in interventional pulmonology.

Steve DimmerinFounder

Dennis Wahr inPresident & CEODennis Wahr is a physician and medical device entrepreneur who previously co-founded and led Lutonix (acquired by CR Bard in 2011) and Velocimed (acquired by St. Jude Medical in 2005), and trained as an interventional cardiologist before transitioning to entrepreneurship and venture investing.

Lisa Flaherty inChief Strategy OfficerChief Strategy Officer at Nuvaira, Lisa Flaherty brings 25 years of medical device experience spanning clinical program development, market development, and commercial strategy. Her background includes transitioning medical technologies from clinical research to standards of care.

Steve Sathre inVice President of FinanceVice President of Finance at Nuvaira, Steve Sathre has held roles in Big 4 accounting, private growth-stage companies, and publicly traded corporations.

Steve PaidoshVice President of Operations

Dennis Wahr M.D.inCEODennis Wahr is an interventional cardiologist who co-founded Velocimed (acquired by St. Jude Medical in 2005) and Lutonix (acquired by CR Bard in 2011), serving as President and CEO of each. He joined Nuvaira as President and CEO in 2012 and has held board positions at multiple medical device companies including Accumetrics, IDev, and Intact Vascular.

Board

Geoffrey DuykBoard director

Doug SissonBoard director

Kirk NielsenBoard director

Dave StassenBoard director

Mark Deem inBoard directorOperating Partner at Lightstone Ventures

Investors · 3

Windham Capital PartnersNew York · $1M – $5M

Lightstone VenturesreportedPortola Valleyvia Mike Carusi · board

Qiming Venture PartnersreportedBeijing · $5M – $134Mvia Gary Rieschel · board

Reported raises · per SEC filings

Form D private placements

$154.3M disclosed across 8 rounds · 2014–2026

▶$35.8MraisedMar 2026 · 9 investors · Other Health Care

Rule 506(b)